Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

135.87
Delayed Data
As of 4:00pm ET
 +0.57 / +0.42%
Today’s Change
109.12
Today|||52-Week Range
163.71
+11.05%
Year-to-Date
Research Reports on Exxon, P&G and the Q4 Earnings Season
12:51pm / Zacks.com - Paid Partner Content
Here's Why Alexion Pharmaceuticals, Inc. Stock Gave Up 36% in 2016
Jan 09 / MotleyFool.com - Paid Partner Content
4 Top Biotech Mutual Funds for 2017
10:42am / Zacks.com - Paid Partner Content
Alexion Blood Disorder Drug Gets Orphan Designation in U.S.
Jan 09 / Zacks.com - Paid Partner Content
Drugmakers alarmed by Trump pricing threat
Jan 14 / FT.com - Paid Partner Content
Company News for January 06, 2017
Jan 06 / Zacks.com - Paid Partner Content
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan 12 / Zacks.com - Paid Partner Content
Alexion (ALXN) Stock Up on 10Q Filing; 2016 View Retained
Jan 05 / Zacks.com - Paid Partner Content
Here Is Why Red-Hot Alexion Is Only Suitable for Risk Takers Now
Jan 11 / TheStreet.com - Paid Partner Content
Alexion (ALXN): Will the Stock Continue to Suffer in 2017?
Jan 04 / Zacks.com - Paid Partner Content
Alexion (ALXN) Files for Label Expansion of Soliris in U.S., EU
Jan 11 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study I...
Jan 04 / Zacks.com - Paid Partner Content